The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in ...
FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.
Researchers have employed Bayesian neural network approaches to evaluate the distributions of independent and cumulative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results